Role of a STAT binding site in the regulation of the human perforin promoter

Journal of Immunology

Volumn 162, Issue 5, 1999, Pages 2785-2790

  Yu, Cheng Rong ^a,b   Ortaldo, John R ^a   Curiel, Rafael E ^a   Young, Howard A ^a   Anderson, Stephen K ^a,c   Gosselin, Pierre ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 6; LUCIFERASE; PERFORIN; STAT1 PROTEIN; STAT5 PROTEIN; STAT5B PROTEIN;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REPORTER GENE;

BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; MILK PROTEINS; PORE FORMING CYTOTOXIC PROTEINS; PROMOTER REGIONS (GENETICS); STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

EID: 0033105650     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Podack, E. R., H. Hengartner, and M. G. Lichtenheld. 1991. A central role of perforin in cytolysis? Annu. Rev. Immunol. 9:129.
2. Shinkai, Y., K. Takio, and K. Okumura. 1988. Homology of perforin to the ninth component of complement (C9). Nature 334:525.
3. Young, J. D., H. Hengartner, E. R. Podack, and Z. A. Cohn. 1986. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell 44:849.
4. Masson, D., and J. Tschopp. 1985. Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. J. Biol. Chem. 260:9069.
5. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkemagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
6. + T cells. J. Exp. Med. 171:1269.
7. Trapani, J. A., B. S. Kwon, C. A. Kozak, C. Chintamaneni, J. D. Young, and B. Dupont. 1990. Genomic organization of the mouse pore-forming protein (perforin) gene and localization to chromosome 10: similarities to and differences from C9. J. Exp. Med. 171:545.
8. Youn, B. S., C. C. Liu, K. K. Kim, J. D. Young, M. H. Kwon, and B. S. Kwon. 1991. Structure of the mouse pore-forming protein (perforin) gene: analysis of transcription initiation site, 5′ flanking sequence, and alternative splicing of 5′ untranslated regions. J. Exp. Med. 173:813.
9. Lichtenheld, M. G., and E. R. Podack. 1989. Structure of the human perforin gene: a simple gene organization with interesting potential regulatory sequences. J. Immunol. 143:4267.
10. Trapani, J. A., and B. Dupont. 1990. Novel putative promoter/enhancer sequences are shared by the mouse and human perforin (Pfp) genes. Tissue Antigens 36:228.
11. Lichtenheld, M. G., and E. R. Podack. 1992. Structure and function of the murine perforin promoter and upstream region: reciprocal gene activation or silencing in perforin positive and negative cells. J. Immunol. 149:2619.
12. Koizumi, H., M. F. Horta, B. S. Youn, K. C. Fu, B. S. Kwon, J. D. Young, and C. C. Liu. 1993. Identification of a killer cell-specific regulatory element of the mouse perforin gene: an Ets-binding site-homologous motif that interacts with Ets-related proteins. Mol. Cell. Biol. 13:6690.
13. Youn, B. S., K. K. Kim, and B. S. Kwon. 1996. A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene. J. Immunol. 157:3499.
14. Zhang, Y., and M. G. Lichtenheld. 1997. Non-killer cell-specific transcription factors silence the perforin promoter. J. Immunol. 158:1734.
15. Darnell, J. E. J. 1997. STATs and gene regulation. Science 277:1630.
16. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331.
17. Salvucci, O., F. Mami-Chouaib, J. L. Moreau, J. Theze, J. Chehimi, and S. Chouaib. 1996. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4. Eur. J. Immunol. 26:2736.
18. Smyth, M. J., J. R. Ortaldo, W. Bere, H. Yagita, K. Okumura, and H. A. Young. 1990. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J. Immunol. 145:1159.
19. Smyth, M. J., Y. Norihisa, J. R. Gerard, H. A. Young, and J. R. Ortaldo. 1991. IL-7 regulation of cytotoxic lymphocytes: pore-forming protein gene expression, interferon-γ production, and cytotoxicity of human peripheral blood lymphocytes subsets. Cell. Immunol. 138:390.
20. DeBlaker-Hohe, D. F., A. Yamauchi, C. R. Yu, J. A. Horvath-Arcidiacono, and E. T. Bloom. 1995. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell. Immunol. 165:33.
21. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431.
22. Kaplan, M. H., Y. L. Sun, T. Hoey, and M. J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174.
23. Timonen, T., J. R. Ortaldo, and R. B. Herberman. 1981. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med. 153:569.
24. Queen, C., and D. Baltimore. 1983. Immunoglobulin gene transcription is activated by downstream sequence elements. Cell 33:741.
25. Yu, C. R., J. X. Lin, D. W. Fink, S. Akira, E. T. Bloom, and A. Yamauchi. 1996. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-α. J. Immunol. 157:126.
26. Bowen, M. A., K. J. Olsen, L. Cheng, D. Avila, and E. R. Podack. 1993. Functional effects of CD30 on a large granular lymphoma cell line, YT: inhibition of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation. J. Immunol. 151:5896.
27. Berberich, S. J., and E. H. Postel. 1995. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element. Oncogene 10:2343.
28. Meyer, W. K., P. Reichenbach, U. Schindler, E. Soldaini, and M. Nabholz. 1997. Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor a gene transcription. J. Biol. Chem. 272:31821.
29. Rosenthal, L. A., K. D. Winestock, and D. S. Finbloom. 1997. IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts. Cell. Immunol. 181:172.
30. Hou, J., U. Schindler, W. J. Henzel, S. C. Wong, and S. L. McKnight. 1995. Identification and purification of human STAT proteins activated in response to interleukin-2. Immunity 2:321.
31. Yu, C. R., H. A. Young, and J. R. Ortaldo. 1998. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells. J. Leukocyte Biol. 64:245.